boston.com Your Life your connection to The Boston Globe
White Coat Notes: News from the Boston-area medical community
Comments
Send your comments and tips to whitecoat@globe.com
Categories


Blogger
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Contributors
Boston Globe Health and Science staff:
Scott Allen
Alice Dembner
Carey Goldberg
Liz Kowalczyk
Stephen Smith
Colin Nickerson
Beth Daley
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
 Short White Coat blogger Ishani Ganguli
 Short White Coat blogger Jennifer Srygley
Week of: November 11
Week of: November 4
Week of: October 28
Week of: October 21
Week of: October 14
Week of: October 7

« In case you missed it: lessons from heart disease | Main | MGH group to study genes and heart attacks »

Monday, April 9, 2007

Today's Globe: anti-anemia drug roadblocks, AIDS orphans, bed sores, new hepatitis drug

A licensing deal between Beth Israel Deaconess Medical Center and a Florida biotechnology company to produce a "super" form of an anti-anemia drug is in danger of foundering just two years after it was signed.

As the creator of the first global center dedicated exclusively to health and human rights, at the Harvard School of Public Health, Countess Albina du Boisrouvray probably has as much hands-on experience in both as anyone. She's adopted the world's AIDS orphans as her cause.

Until recently, most experts believed that bed sores were an unambiguous indicator of bad care.

Also in Health/Science, the power of trash, Scrabble as a science and drug combinations.

In Business & Innovation, for Vertex Pharmaceuticals Inc., the future hinges on a potential billion-dollar drug for hepatitis C and a liver-research conference about to kick off 3,700 miles away in Spain where it will unveil new data from human trials of the pill.

Posted by Elizabeth Cooney at 06:25 AM
Sponsored Links